https://www.dailyhealthindustry.it/batteri-farmaco-resistenti-germania-entra-nel-progetto-carb-x/ 2019-03-18T14:36:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/best-workplaces-italia-2019-abbvie-prima-tra-le-pharma/ 2019-03-18T16:42:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apple-watch-rileva-frequenze-cardiache-irregolari/ 2019-03-18T16:08:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stryker-acquisisce-orthospace-e-avanza-nella-medicina-sportiva/ 2019-03-18T16:07:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-premia-linnovazione-digitale-in-ambito-salute/ 2019-03-19T08:54:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nuova-indicazione-per-praluent/ 2019-03-19T14:09:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-keytruda-alla-conquiista-del-mercato-cinese/ 2019-03-19T14:22:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/molmed-i-risultati-2018/ 2019-03-19T15:38:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/irhythm-funziona-il-cerotto-ecg/ 2019-03-19T15:58:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-accordo-con-teva-per-generici-victoza/ 2019-03-19T16:15:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/molmed-ok-aifa-a-sperimentazione-terapia-car-t-in-aml-e-mm/ 2019-03-20T15:29:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-ottimi-risultati-per-dostarlimab-nel-carcinoma-endometriale/ 2019-03-20T11:42:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-editing-genetico-presto-quadro-di-riferimento-certo-e-trasparente/ 2019-03-20T11:59:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-a-fda-ed-ema-domanda-per-ofev-nella-sclerodermia/ 2019-03-20T14:02:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-prepara-il-dopo-brandicourt/ 2019-03-20T15:29:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chan-zuckerberg-initiative-scommette-sulla-microscopia-digitale/ 2019-03-20T17:04:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-partnership-con-affibody-per-candidato-malattie-igg-mediate/ 2019-03-21T11:49:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/illumina-messa-a-punto-biopsia-liquida-ad-elevata-sensibilita/ 2019-03-21T12:03:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-richiesta-a-fda-per-ozempic-orale/ 2019-03-21T14:30:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-1-mld-di-euro-per-il-sito-di-darmstadt/ 2019-03-21T14:52:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-shopping-pfizer-punta-la-francese-vivet/ 2019-03-21T15:28:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-animal-health-vendita-o-spin-off/ 2019-03-21T16:28:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-collaborazione-con-exscientia-per-tre-small-molecule/ 2019-03-22T10:15:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fresenius-nuovo-centro-mondiale-per-coordinare-ricerca-e-sviluppo/ 2019-03-22T10:42:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/thermo-fisher-150-mln-di-dollari-per-i-siti-produttivi-anche-in-italia/ 2019-03-22T11:26:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/smiths-group-via-lhealthcare-unit-sara-quotata-in-uk/ 2019-03-22T14:08:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-buoni-risultati-da-candidato-contro-mieloma-multiplo/ 2019-03-22T14:32:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-eisai-stop-a-due-studi-su-candidato-alzheimer/ 2019-03-25T14:24:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eisai-riprende-studi-su-candidato-ban-2401-per-alzheimer/ 2019-03-25T12:55:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/convatec-karim-bitar-nuovo-ceo/ 2019-03-25T12:54:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-certificazione-ce-per-famiglia-analizzatori-alinity-m/ 2019-03-25T14:46:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/thermo-fischer-acquisisce-brammer-bio/ 2019-03-25T15:16:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-si-a-separazione-ceo-e-presidente-ma-dopo-saunders/ 2020-11-10T09:01:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/drugs-to-watch-i-magnifici-sette-del-2019/ 2019-03-25T16:34:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-ce-a-forxiga-nel-diabete-di-tipo-1/ 2019-03-26T10:37:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-pieno-sostegno-al-management-dopo-nuovo-verdetto-roundup/ 2019-03-26T11:27:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-buy-back-per-5-mld-di-dollari/ 2019-03-26T14:44:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-arriva-il-supermanager/ 2019-03-26T15:19:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibm-algoritmo-per-studiare-lapoptosi-cellulare/ 2019-03-26T16:08:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alcon-addio-a-novartis-dopo-8-anni/ 2019-03-26T16:50:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-vision-efficaci-le-lenti-a-contatto-con-antistaminico/ 2019-03-27T16:00:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-celgene-ftc-americana-chiede-informazioni-sui-trattamenti-per-la-psoriasi/ 2019-03-27T16:00:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-opa-ostile-a-versum/ 2019-03-27T16:23:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-luce-verde-fda-per-mayzent-nella-spms/ 2019-03-27T15:18:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-deal-or-non-deal-ecco-il-vademecum-ema/ 2019-03-27T15:36:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/illumina-alla-ricerca-delle-radici-delle-patologie-neuropsichiatriche/ 2019-03-27T15:58:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/esaote-nuova-campagna-di-comunicazione/ 2019-03-28T14:10:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-dal-giappone-il-primo-si-a-skyrizi/ 2019-03-28T14:17:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/md-i-ricercatori-chiedono-alla-fda-nuove-norme-su-sicurezza/ 2019-03-28T14:38:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-alla-fda-il-nuovo-dossier-su-ozanimod/ 2019-03-28T15:13:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dispositivi-medici-massimiliano-boggetti-presidente/ 2019-03-28T15:38:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-avanza-polyneuron-startup-svizzera/ 2019-03-28T15:58:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bluebird-bio-le-nuove-frontiere-della-gene-therapy/ 2019-03-29T18:03:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ingegneri-clinici-nascita-confindustria-dm-e-un-grande-segnale/ 2019-03-29T14:35:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-e-daiichi-sankyo-accordo-da-7-mld-di-dollari/ 2019-03-29T14:49:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-altro-investimento-nel-sito-produttivo/ 2019-03-29T15:01:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-vaccines-a-siena-nuovo-edificio-per-controllo-qualita-vaccini/ 2019-03-29T16:28:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-e-la-dimensione-del-raro-per-gli-italiani/ 2019-03-29T17:59:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nasce-la-linea-embrance/ 2019-04-02T12:57:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genfit-unaltra-biotech-al-nasdaq/ 2019-04-01T13:42:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gamification-arriva-cardio-ex/ 2019-04-01T16:14:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-combo-opdivo-yervoy-efficace-nei-tumori-neuroendocrini/ 2019-04-01T16:49:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-antibiotici-si-puo-dare-di-piu/ 2019-04-01T15:21:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/molmed-riccardo-palmisano-nel-cd-del-cluster-lombardo-scienze-della-vita/ 2019-04-01T16:46:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apexigen-bene-combo-con-opdivo-nel-tumore-del-pancreas/ 2019-04-02T13:29:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zentiva-acquisisce-creo-pharmaceuticals/ 2019-04-02T13:38:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-celgene-si-arrende-lhedge-fund-starboard/ 2019-04-02T13:55:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-primi-dati-sul-secondo-inibitore-trk/ 2019-04-02T14:43:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-car-t-nuove-speranze-per-i-tumori-solidi/ 2019-04-02T15:20:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-cancro-dal-modello-istologico-a-quello-mutazionale/ 2019-04-02T17:13:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ultima-chiamata-per-luxturna/ 2019-04-03T16:22:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/manager-attratti-dalle-biotech-ian-smith-ceo-di-artios-pharma/ 2019-04-03T13:40:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-supervisory-board-difende-affare-monsanto/ 2019-04-03T14:19:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/puma-a-pierre-fabre-i-diritti-europei-di-nerlynx/ 2019-04-03T15:09:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-la-cina-dice-si-a-cosentyx/ 2019-04-03T15:34:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-combo-keytruda-chemioterapia-efficace-nel-nsclc-con-metastasi/ 2019-04-03T16:11:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-la-svizzera-medacta-va-in-borsa/ 2019-04-04T13:55:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/illumina-nuova-biopsia-liquida-per-nsclc/ 2019-04-04T13:54:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-come-cambieranno-in-uk-gli-studi-clinici/ 2019-04-04T14:54:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alcon-si-quota-alla-borsa-svizzera/ 2019-04-04T14:54:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-nuovo-quadro-normativo-per-dm-basati-su-intelligenza-artificiale/ 2019-04-04T17:41:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jeff-bezos-con-billa-gates-nella-battaglia-contro-lalzheimer/ 2019-04-04T16:09:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-pfizer-la-venture-degli-otc-punta-a-usa-e-cina/ 2019-04-05T17:06:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/myriad-al-via-studio-su-test-diagnostico-con-astrazeneca-e-msd/ 2019-04-05T13:39:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gottlieb-prezzi-piu-bassi-e-maggiore-concorrenza/ 2019-04-05T14:09:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-jv-con-chr-hansen-per-produrre-bioterapeutici/ 2019-04-05T14:46:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-e-amgen-e-battaglia-legale-su-aimovig/ 2019-04-05T15:11:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zolgensma-allesame-dellicer/ 2019-04-05T16:11:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-biofarma-italia-annalisa-calvano-nuovo-direttore-stabilimento-di-modugno/ 2020-11-10T08:56:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marketing-pharma-lera-del-paziente-consumatore/ 2019-04-08T13:31:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunologia-mercato-saturo-ce-chi-dice-no/ 2019-04-08T13:47:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/clovis-oncology-nuove-evidenze-per-rubraca-nel-tumore-del-pancreas/ 2019-04-08T14:23:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-ecco-la-top-15-del-2018/ 2019-04-08T15:30:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-da-studi-sword-conferme-per-combo-dolutegravir-rilpivirina/ 2019-04-08T16:49:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-versum-si-fa/ 2019-04-09T17:10:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-accordo-con-alnylam-per-terapie-basate-su-silenziamento-genico/ 2019-04-09T13:02:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/iapg-regole-certe-e-innovazione-per-la-farmaceutica-in-italia/ 2019-04-09T13:34:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-ok-fda-a-dovato/ 2019-04-09T15:45:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-10-mld-di-dollari-da-spendere-in/ 2019-04-09T14:31:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-fda-a-ibrance-nel-tumore-mammario-maschile-grazie-al-real-world/ 2019-04-09T15:13:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-collaborazione-con-biotech-ai-per-studi-real-world-in-oncologia/ 2019-04-10T13:55:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/s13213/ 2019-04-10T14:00:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-oftalmologia-comincia-il-dopo-alcon/ 2019-04-10T14:21:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pasteur-al-via-seconda-edizione-contest-e-hackathon-su-comunicazione-vaccini/ 2019-04-10T15:11:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-ok-fda-a-evenity/ 2019-04-10T15:31:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cyclerion-malattie-rare-ex-di-shire-nuovo-chief-innovation-officer/ 2019-04-10T16:01:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-e-cuamm-con-lafrica-investire-sulle-donne-per-investire-sul-futuro/ 2019-04-11T13:03:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-venti-anni-di-meloxicam/ 2019-04-11T13:19:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-philips-insieme-per-la-telemedicina/ 2019-04-11T13:50:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pierrel-goccles-medaglia-dargento-degli-edison-awards-2019/ 2019-04-11T15:18:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alcon-ottimo-debutto-in-borsa/ 2019-04-11T15:38:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-deka-investment-chiede-conto-dellacquisizione-di-monsanto/ 2019-04-11T16:41:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-farmacia-del-futuro-secondo-dario-francolino/ 2019-04-12T13:18:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-cloud-e-deloitte-collaborazione-per-ai-nelle-life-sciences/ 2019-04-12T13:33:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-neurodegenerative-nasce-athira-pharma/ 2019-04-12T13:48:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-sempre-maggiore-autonomia/ 2019-04-12T14:29:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ok-a-dispositivo-indossabile-per-la-bpco/ 2019-04-12T15:01:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaceutica-stipendi-top-per-impiegati-e-quadri/ 2019-04-12T17:16:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-celgene-ok-degli-azionisti-alla-fusione/ 2019-04-15T13:43:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-ok-fda-a-balversa-nel-tumore-avanzato-della-vescics/ 2019-04-15T13:06:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aaa-aifa-approva-lutathera/ 2019-04-15T13:35:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-e-gilead-insieme-per-combo-contro-la-nash/ 2019-04-15T14:06:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-programma-con-dati-real-world-per-studi-randomizzati/ 2019-04-15T14:28:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/small-data-la-prossima-frontiera-nello-sviluppo-dei-farmaci/ 2019-04-15T15:17:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-societa-di-consulenza-con-saunders/ 2019-04-16T16:49:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-evenity-costera-quasi-2-mila-dollari-al-mese/ 2019-04-16T13:33:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intercept-nuovi-dati-positivi-su-oca-nella-nash/ 2019-04-16T14:29:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eip-pharma-nuova-vita-per-ex-farmaco-vertex/ 2019-04-16T14:51:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-cart-il-futuro-passa-per-i-nanobodie/ 2019-04-16T15:55:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/un-altro-merger-nella-terapia-genica-catalent-prende-paragon-per-1-mld-di-dollari/ 2019-04-16T16:16:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-il-q1alza-le-stime-per-il-2019/ 2019-04-17T13:50:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/recordati-tutto-pronto-per-cystagon-in-canada/ 2019-04-17T13:49:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-q1-allinsegna-di-stelara/ 2019-04-17T14:26:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmacie-arriva-in-italia-walgreens-boots-alliance/ 2019-04-17T15:04:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genscript-nuovo-impianto-in-cina-per-cdmo-internazionale/ 2019-04-17T16:37:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/thermo-fisher-lancia-sistemi-pcr-intelligenti/ 2019-04-17T17:33:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/polifarma-compie-100-anni/ 2019-04-18T13:33:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-100-mln-di-euro-per-ricostruire-notre-dame/ 2019-04-18T14:08:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-performance-q1-battono-le-stime/ 2019-04-18T13:48:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-un-buon-2018-ma-cala-lutile-operativo/ 2019-04-18T14:40:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-comincia-lera-sharpless/ 2020-11-10T08:56:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/microsoft-e-dnanexus-pronta-piattaforma-di-oncologia-pediatrica/ 2019-04-18T15:48:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-pfizer-ok-fda-a-keytruda-inlyta-nel-tumore-al-rene/ 2019-04-23T17:22:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-fda-approva-spray-al-naloxone/ 2019-04-23T15:33:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/car-t-studio-usa-apre-nuove-prospettive/ 2019-04-23T16:25:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aduro-biotech-il-nuovo-cmo-viene-da-pfizer/ 2019-04-23T16:47:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-disco-verde-fda-per-skyrizi/ 2019-04-24T10:36:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-nuovi-interessi-in-cina/ 2019-04-24T10:55:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-stop-ad-ajovy-nel-trattamento-delle-cefalee-a-grappolo/ 2019-04-24T11:21:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nel-q1-vendite-al-top-con-entresto-e-cosentyx/ 2019-04-24T14:44:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lancio-del-farmaco-ci-pensa-lai/ 2019-04-24T15:22:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-ok-chmp-a-cemiplimab/ 2019-04-29T13:09:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-tagrisso-trascina-il-q1/ 2019-04-29T13:37:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-caso-monsanto-allassemblea-generale-gli-azionisti-strigliano-il-board/ 2019-04-29T16:59:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-q1-sottotono-ma-crescita-confermata/ 2019-04-29T14:41:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-struttura-produttiva-in-iran-per-il-mercato-domestico/ 2019-04-29T15:55:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-bene-il-q1-grazie-a-vendite-malattie-rare-e-vaccini/ 2019-04-29T16:16:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-per-elezioni-2020-niente-soldi-dalle-pharma/ 2019-04-30T13:16:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-accordo-con-pharma-taiwan-per-biosimilare-herceptin/ 2019-04-30T14:31:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-e-boston-university-insieme-per-studio-su-tumore-del-polmone/ 2019-04-30T14:53:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nhs-england-con-gilead-msd-e-abbvie-per-eradicazione-epatite-c/ 2019-04-30T15:19:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-allema-il-dossier-su-luspatercept/ 2019-04-30T16:08:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-slitta-al-3-giugno-closing-acquisizione-spark/ 2019-04-30T16:26:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-saunders-rimane-in-sella/ 2019-05-02T13:38:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-e-shingrix-boom/ 2019-05-02T14:12:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/smith-crescono-le-vendite-nei-mercati-emergenti/ 2019-05-02T14:32:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/molmed-nuovo-cda-confermati-nelle-cariche-incerti-e-palmisano/ 2020-11-10T08:56:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/arriva-nimble-therapeutics-spinout-di-roche/ 2019-05-02T15:51:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fresenius-q1-positivo-vendite-e-utile-operativo-in-crescita/ 2019-05-02T16:20:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-via-libera-a-dispositivo-iqos-di-philip-morris/ 2019-05-02T16:48:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-kite-pharma-sara-bu-separata/ 2019-05-03T13:28:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-trelegy-ellipta-raggiunge-endpoint-in-studio-su-asma/ 2019-05-03T13:52:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-continua-la-cura-dimagrante/ 2019-05-03T14:35:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-sonda-pazienti-e-industria-su-md-del-futuro/ 2019-05-03T14:57:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-nuova-vita-per-selumetinib/ 2019-05-03T16:05:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-fda-a-dengvaxia-ma-solo-dai-9-ai-16-anni/ 2019-05-03T16:31:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ozempic-mette-il-turbo-nel-q1/ 2019-05-06T12:33:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-nuovi-dati-su-sicurezza-e-tollerabilita-spinraza/ 2019-05-06T13:21:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-concluso-il-progetto-heva/ 2019-05-06T13:53:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-accordo-con-syapse-per-studi-oncologici-real-world/ 2019-05-06T14:12:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-e-transgene-insieme-per-sviluppare-virus-oncolitici/ 2019-05-06T16:44:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nuovi-dati-su-aimovig/ 2019-05-06T17:17:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-per-skyrizi-via-libera-anche-dalla-ce/ 2019-05-07T10:56:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-acquisisce-la-biotech-abide-therapeutics/ 2019-05-07T11:23:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/promethera-via-a-studio-hepastem-nella-nash-terminale/ 2019-05-07T12:31:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/13433/ 2019-05-07T12:48:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-sostiene-il-progetto-obecity/ 2019-05-07T13:36:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-accordo-per-sviluppo-small-molecule-in-campo-neurologico/ 2019-05-07T15:02:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-saunders-bisogna-far-risalire-le-azioni/ 2019-05-08T11:09:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-daiichi-sankyo-funziona-nuovo-trattamento-tumore-al-seno/ 2019-05-08T12:41:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-q1-2019-al-di-sotto-delle-attese/ 2019-05-08T16:01:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-farmaco-pediatrico-per-sindrome-lambert-eaton/ 2019-05-08T13:47:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-lancio-in-usa-campagna-test-genomici-in-oncologia/ 2019-05-08T15:22:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nuovi-dati-su-zolgensma/ 2019-05-08T15:45:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-cede-a-xiidra-a-novartis/ 2019-05-09T13:49:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-una-app-per-la-depressione-da-sm/ 2019-05-09T14:04:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-aumenta-la-produzione-mondiale-di-gardasil/ 2019-05-09T17:18:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ecco-hidradisk-app-per-lidrosadenite-suppurativa/ 2019-05-09T14:51:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomarin-ok-ce-a-palynziq-nella-pku/ 2019-05-09T15:42:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/3m-e-copag-insieme-nella-lotta-alle-infezioni-correlate-allassistenza/ 2019-05-09T16:10:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-un-futuro-da-player-dei-servizi-integrati/ 2019-05-10T13:39:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boston-scientific-acquisisce-vertiflex/ 2019-05-10T13:51:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-su-theracon-biotech-specializzata-in-malattie-rare/ 2019-05-10T14:07:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-per-il-nice-ocrevus-e-cost-effective/ 2019-05-10T14:32:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-a-dupilumab-nel-trattamento-dellasma-grave/ 2019-05-10T14:48:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-bond-fino-2049-per-finanziare-acquisizione-celgene/ 2019-05-10T17:06:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lillly-emgality-supera-aimovig-per-pazienti-in-trattamento/ 2019-05-15T08:16:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-gilead-dona-ai-cdc-oltre-2-mln-di-confezioni-di-truvada/ 2019-05-13T14:39:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-tutto-pronto-per-i-lancio-di-zolgensma/ 2019-05-13T15:16:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-generici-20-aziende-indagate-in-usa/ 2019-05-13T15:30:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-emofilia-una-corsa-a-colori-verso-nuovi-traguardi/ 2019-05-13T15:46:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/esaote-franco-fontana-nuovo-ceo/ 2020-11-10T09:01:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ministro-grillo-ho-chiesto-alloms-maggiore-trasparenza-su-prezzi-farmaci/ 2019-05-13T16:55:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-e-philips-insieme-nella-fibrillazione-atriale/ 2019-05-14T12:45:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-leggera-flessione-degli-utili-nel-2019/ 2019-05-14T13:03:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ingegneri-clinici-dal-16-maggio-convegno-a-catanzaro/ 2019-05-14T13:47:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-pronta-a-cedere-la-linea-coppertone/ 2019-05-14T14:12:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philogen-biotech-italiana-ottiene-un-finanziamento-da-62-mln-di-euro/ 2019-05-14T14:38:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/molmed-q1-in-linea-con-le-aspettative/ 2019-05-14T15:39:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-accordo-su-spinraza-con-nhs-inglese/ 2019-05-15T12:56:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-kymriah-approvata-in-giappone/ 2019-05-15T13:12:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-panel-fda-dice-no-a-quizartinib/ 2019-05-15T13:44:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-utile-operativo-in-calo-fino-al-2020/ 2019-05-15T14:30:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-e-la-rivoluzione-digitale/ 2019-05-15T15:42:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-ok-fda-a-cyramza-nel-trattamento-del-cancro-del-fegato/ 2019-05-15T16:13:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/riccardo-palmisano-confermato-presidente-assobiotec/ 2019-05-16T13:35:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alcon-bene-il-q1-e-stime-positive-per-il-2019/ 2019-05-16T13:45:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-genzyme-al-via-la-quarta-edizione-di-make-to-care/ 2019-05-16T14:07:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-e-aism-colazione-in-centro-per-parlare-di-sm-e-qualita-della-vita/ 2019-05-16T14:28:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nestle-pronta-a-cedere-skin-health-a-consorzio-di-abu-dhabi/ 2019-05-16T14:55:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-consumer-healthcare-francesco-cantini-vp-e-gm-italia-grecia-e-israele/ 2020-11-10T08:55:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leo-pharma-italia-arriva-brodalumab-aifa-approva-rimborsabilita/ 2019-05-16T16:03:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-primi-risultati-del-candidato-a-target-kras/ 2019-05-17T13:06:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/industria-chmica-emiliana-quattro-private-equity-in-corsa-per-lacquisto/ 2019-05-17T13:29:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/congresso-aiic-sinergia-tra-industria-e-ssn-nuovo-modello-di-governance/ 2019-05-17T13:59:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/thermo-fischer-acquisisce-un-sito-in-irlanda-da-gsk/ 2019-05-17T14:32:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosense-webster-nel-cloud-piattaforma-per-collegare-i-dispositivi-fa/ 2019-05-17T15:54:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/uk-al-via-progetto-di-studio-su-farmaci-evolutivi-per-il-cancro/ 2019-05-17T16:15:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-per-il-gastrointestinale-nasce-phathom-pharmaceuticals/ 2019-05-20T13:22:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celltrion-pronti-oltre-30-mld-di-dollari-per-i-prossimi-10-anni/ 2019-05-20T13:40:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ionis-pharmaceuticals-new-branding-per-i-30-anni/ 2019-05-20T14:18:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-ok-del-nice-a-revlimid/ 2019-05-20T14:41:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-un-mercato-ancora-difficile/ 2019-05-20T15:51:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-designati-i-vincitori-al-via-i-bootcamp-della-prima-edizione/ 2019-05-24T13:47:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-accordo-con-parvus-per-sviluppare-farmaci-contro-malattie-autoimmuni/ 2019-05-21T16:57:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-entra-nel-progetto-brain/ 2019-05-21T13:48:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-compra-linea-aspen-per-laustralia-e-la-nuova-zelanda/ 2019-05-21T16:32:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-qual-e-il-prezzo-giusto-per-zolgensma/ 2019-05-21T14:48:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-shingrix-stellare-ma-soffre-lhiv/ 2019-05-21T16:08:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-animal-health-italia-tutorial-per-la-ricetta-veterinaria-elettronica/ 2019-05-21T16:18:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shionogi-e-molteni-accordo-per-lancio-rizmoic-in-italia-e-polonia/ 2019-05-22T10:31:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-ok-ce-per-regimi-associazione-con-tripletta-a-base-di-revlimid-e-imnovid/ 2019-05-22T10:47:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-buoni-i-dati-a-tre-mesi-per-galcanezumab/ 2019-05-22T15:00:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/evotec-acqusisce-una-cdmo/ 2019-05-22T15:20:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovo-accordo-per-le-terapie-geniche-catalent-compra-paragon-bioservices/ 2019-05-22T15:35:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/wuxi-biologics-contratto-faraonico-per-produrre-un-vaccino/ 2019-05-22T15:51:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-una-piattaaforma-per-i-farmaci-antinfiammatori/ 2019-05-23T13:44:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sakyo-verso-la-vendita-degli-otc/ 2019-05-23T13:43:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-geniche-scienziati-italiani-individuano-metodo-per-migliorare-vettori/ 2019-05-23T13:58:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-shingrix-sbarca-in-cina/ 2019-05-23T14:50:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-verso-una-nuova-concezioone-dei-dm/ 2019-05-23T16:07:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ai-di-google-batte-un-team-di-radiologi/ 2019-05-23T16:13:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spira-health-al-via-sperimentazione-dispositivo-indossabile-per-la-bpco/ 2019-05-24T13:40:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-acquisisce-peloton/ 2019-05-24T13:56:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-narasimhan-e-presto-per-acquistare-in-cina/ 2019-05-24T14:17:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-investe-in-messico/ 2019-05-24T14:30:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scott-gottlieb-torna-alla-sua-venture-capital/ 2019-05-24T14:45:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-cambiano-gli-incentivi-per-gli-informatori-farmaceutici/ 2019-05-24T15:20:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/grillo-le-aziende-hanno-pagato-il-payback-2013-2017/ 2019-05-24T16:58:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-fda-a-zolgesma-prezzo-record-di-2-mln-di-dollari/ 2019-05-27T13:39:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-via-libera-fda-a-jakafi-nel-trattamento-della-gvhd/ 2019-05-27T14:03:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boheringer-ingelheim-bene-nintedanib-nella-malattia-polmonare-intestiziale/ 2019-05-27T14:42:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-seno-arriva-piqray-di-novartis/ 2019-05-27T17:31:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novocure-arriva-il-primo-dispositivo-per-il-mesotelioma-pleurico/ 2019-05-27T16:27:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-prezzi-dei-farmaci-in-settimana-la-decisione-di-trump/ 2019-05-27T16:12:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-obiettivo-diversificazione/ 2019-05-28T13:39:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-dei-farmaci-loms-accetta-la-proposta-dellitalia/ 2019-05-28T14:15:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-fda-approva-due-test-per-le-ist/ 2019-05-28T14:26:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-in-gu-il-bando-per-la-ricerca-indipendente-sui-farmaci/ 2019-05-28T14:51:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-priority-review-per-invokana-nella-malattia-renale-cronica/ 2019-05-28T15:16:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cannes-lions-health-ecco-la-giuria/ 2019-05-28T15:26:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-fda-estende-vravylar-a-episodi-depressivi-disturbo-bipolare/ 2019-05-29T13:08:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-bene-combo-avastin-tecentriq-nel-tumore-renale/ 2019-05-29T13:19:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-cina-motore-della-crescita-per-i-farmaci-innovativi/ 2019-05-29T13:52:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomarin-terapia-emofilia-a-efficace-per-otto-anni/ 2019-05-29T14:18:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/13701/ 2019-05-29T15:15:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/thermo-fischer-biopsie-liquide-ngs-monitorano-tumori-polmonari/ 2019-05-29T16:14:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-obiettivo-tumori-early-stage/ 2019-05-30T13:26:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-al-via-collaborazione-con-foundation-medicine-per-vitrakvi/ 2019-05-30T13:36:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-piqray-farmaco-con-due-primati/ 2019-05-30T13:54:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-repatha-e-statine-dimezzano-eventi-cardiovascolari/ 2019-05-30T14:28:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fuga-verso-le-biotech-e-la-volta-del-regista-del-lancio-di-kymriah/ 2019-05-30T14:56:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-upadacitinib-efficace-nei-pazienti-con-ar-attiva/ 2019-05-30T16:20:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/crea-carlo-gaudio-e-massimo-bagarani-nuovi-subcommissari/ 2019-05-30T17:27:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-msd-tumore-del-pancreas-lynparza-raddoppia-sopravvivenza-libera-da-malattia/ 2019-06-03T16:11:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-tumore-del-seno-kisqali-migliora-tassi-di-sopravvivenza/ 2019-06-03T14:07:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/addf-ecco-i-primi-4-progetti-sullalzheimer/ 2019-06-03T14:35:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-oncologici-nel-2018-quindici-nuovi-lanci-negli-usa/ 2019-06-03T17:40:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-apalutamide-e-adt-migliorano-pfs-nel-tumore-prostata-metastatico/ 2019-06-03T16:09:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-efficace-combo-isatuximab-terapia-standard-nel-mm-recidivante/ 2019-06-03T16:35:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-fda-estende-zerbaxa-alla-polmonite-acquisita-in-ospedale/ 2019-06-04T14:24:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-ottimi-risultati-per-candidato-amg510-nel-nsclc/ 2019-06-04T14:48:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-farmaco-sperimentale-riduce-carcinoma-della-vescica/ 2019-06-04T15:09:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-fondo-private-equity-per-la-bu-animal-health/ 2019-06-04T17:26:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-nuove-evidenze-su-yescarta/ 2019-06-04T15:58:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bluebird-bio-ok-ce-a-prima-terapia-genica-per-la-tdt/ 2019-06-04T16:20:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-matteo-scarpis-nuovo-gm-consumer-health-care/ 2019-06-05T12:53:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-fda-approva-emgality-per-la-cefalea-a-grappolo/ 2019-06-05T14:30:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-accordo-con-biotech-usa-per-sviluppo-nuovi-farmaci/ 2019-06-05T14:50:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/saranas-pronto-dispositivo-che-rivela-emorragie-durante-gli-interventi/ 2019-06-05T15:14:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-regeneron-campagna-online-sul-controllo-dellasma/ 2019-06-05T15:37:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-e-sviluppo-ecco-chi-spende-di-piu/ 2019-06-05T16:03:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-calquence-llc-centra-obiettivo-primario-in-studio-fase-avanzata/ 2019-06-06T14:13:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-e-takeda-in-consorzio-di-ricerca-con-governo-del-quebec/ 2019-06-06T15:23:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-xolair-un-futuro-nel-trattamento-della-sinusite/ 2019-06-06T14:23:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/certificazione-b-corporation-al-gruppo-chiesi/ 2019-06-06T15:01:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fresenius-a-rischio-antibiotico-per-stretta-ue-su-produzione/ 2019-06-06T15:22:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asco-2019-tranquilla-non-per-amgen-astrazeneca-e-regeneron/ 2019-06-06T15:46:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-italia-marco-caraglia-e-il-nuovo-gm/ 2019-06-07T08:06:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuovi-dati-positivi-su-xofluza/ 2019-06-07T12:44:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-fda-ok-allesame-di-ozanimod/ 2019-06-07T13:00:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-il-nuovo-ceo-e-paul-hudson-ex-novartis/ 2020-11-10T09:01:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-celgene-valzer-di-poltrone-nella-nuova-organizzazione/ 2019-06-07T15:06:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-via-scozzese-per-combattere-il-cancro/ 2019-06-07T15:15:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-diabete-bene-studio-sul-sistema-indossabile-freestyle-libre/ 2019-06-10T13:37:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-sancito-accordo-fondi-farmacovigilanza-attiva-2015-2017/ 2019-06-10T13:57:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-lancia-la-linea-visualization/ 2019-06-10T14:19:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stada-compra-6-brand-otc-da-gsk/ 2019-06-10T14:42:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-le-prime-sfide-del-neo-ceo-hudson/ 2019-06-10T16:41:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-arriva-il-nuovo-device-sonicision-curved-jaw/ 2019-06-10T16:21:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/toche-ok-fda-a-polivy-nel-linfoma-diffuso-a-grandi-cellule/ 2019-06-11T14:03:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-partnership-con-tidepool-per-integrare-pompe-e-sistemi-di-monitoraggio-con-app/ 2019-06-11T14:18:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ecco-la-top-20-dei-ceo-piu-pagati-con-qualche-sorpresa/ 2019-06-11T14:49:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/thermo-fischer-antitrust-inglese-dice-no-ad-accordo-con-roper/ 2019-06-11T15:12:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-dallo-studio-rewind-nuove-chance-per-trulicity/ 2019-06-11T15:24:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-italia-torna-week-of-possibilities/ 2019-06-11T16:25:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-keytruda-ok-fda-per-il-trattamento-dei-tumori-testa-e-collo/ 2019-06-12T14:07:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-street-artist-e-social-influencer-per-promuovere-pipeline/ 2019-06-12T14:21:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-nuovi-dati-su-sicurezza-ozempic-orale/ 2019-06-12T17:14:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-buoni-risultati-per-invokana-dallo-studio-credence/ 2019-06-12T15:48:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-nuove-evidenze-su-talz-nella-psoriasi/ 2019-06-12T16:17:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-la-combo-iglarlixi-riduce-glicemia-media/ 2019-06-12T16:36:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-genzyme-a-lemgo-il-premio-eccellenza-in-sanita-2019/ 2019-06-13T13:09:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-thomas-schinecker-nuovo-ceo-della-unit-diagnostics/ 2020-11-10T09:01:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-report-hta-su-uso-floseal-in-cardiochirurgia-e-chirurgia-spinale/ 2019-06-13T13:51:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-primo-device-per-adolescenti-con-ibs/ 2019-06-13T14:19:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-partnership-con-genmab-per-sviluppo-successore-darzalex/ 2019-06-13T14:41:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ada-2019-diabete-sempre-piu-malattia-olistica/ 2019-06-13T15:16:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-italia-ad-pasquale-frega-ricevuto-dal-presidente-mattarella-per-premio-bellisario/ 2019-06-14T12:48:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/deutsche-post-dhl-150-mln-di-dollari-per-la-logistica-dei-farmaci-usa/ 2019-06-14T13:14:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hansoh-entra-nel-listino-di-hong-kong-sta-per-nascere-colosso-pharma-cinese/ 2019-06-14T13:35:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-accordo-di-ricerca-su-editing-genetico-con-universita-della-california/ 2019-06-14T13:59:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lions-health-care-pharma-nelladv-osate-di-piu/ 2019-06-14T14:34:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-5-mld-di-euro-nella-ricercaa-di-nuovi-erbicidi/ 2019-06-14T14:54:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-usa-humira-guida-ancora-la-top-20/ 2019-06-17T10:26:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bleubirb-bio-il-prezzo-di-zynteglo-supera-il-milione-e-mezzo-di-euro/ 2019-06-17T10:48:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-acquisisce-array-biopharma/ 2019-06-17T13:04:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/saga-diagnostics-mette-a-punto-nuova-biopsia-liquida/ 2019-06-17T13:21:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/flatiron-michael-vasconcelles-nuovo-cmo/ 2019-06-17T13:50:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-studio-nyu-identifica-nuovo-obiettivo-terapeutico/ 2019-06-17T14:44:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-presentata-ledizione-2019-del-premio-internazionale-fair-play/ 2019-06-17T16:55:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-e-la-week-of-service/ 2019-06-17T16:53:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-italia-e-ied-milano-affrontare-la-sma-in-12-favole/ 2019-06-18T14:37:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-google-accordo-su-big-data/ 2019-06-18T15:14:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-ce-a-lynparza-nel-trattamento-prima-linea-tumore-ovarico-avanzato/ 2019-06-18T15:25:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/13902/ 2019-06-18T15:48:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adaptive-biotechnologies-ipo-al-nasdaq-per-nuova-linea-test-diagnostici/ 2019-06-18T16:16:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-nuovo-sito-di-produzione-in-spagna/ 2019-06-18T16:29:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuova-luce-sulla-sm/ 2019-06-19T14:36:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-la-cinese-fosun-sulla-bu-veterinaria/ 2019-06-19T15:03:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spin-out-astrazeneca-attrae-investimenti-per-candidato-malattia-rara/ 2019-06-19T15:17:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-dal-giappone-prima-approvazione-per-rozlytrek/ 2019-06-19T15:28:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-lancia-nuovo-test-ematico-3-minuti-per-diagnosticare-il-diabete/ 2019-06-19T15:58:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-francia-prima-per-scetticismo/ 2019-06-19T16:16:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-constanza-oliveros-la-direzione-medica-di-astrazeneca-italia/ 2019-06-20T13:18:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-smith-kline-al-via-progetto-sviluppo-ai/ 2019-06-20T13:35:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-catalent-il-sito-di-produzione-bms-di-anagni/ 2019-06-20T13:51:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-verso-la-cessione-dei-farmaci-non-core/ 2019-06-20T14:29:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-si-scinde/ 2019-06-20T15:07:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-si-prepara-alladdio-a-frazier/ 2019-06-20T15:44:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assogenerici-e-il-momento-dei-biosimilari/ 2019-06-21T14:10:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-loceano-dei-big-data/ 2019-06-21T14:52:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/si-possono-convincere-gli-antivaccinisti-non-sui-social/ 2019-06-21T17:31:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cannes-lions-health-vince-lapp-bpco-di-gsk/ 2019-06-21T16:04:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-nuova-scommessa-su-stivarga/ 2019-06-21T16:16:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-cinese-pubblica-elenco-farmaci-a-brevetto-scaduto-che-non-hanno-generici/ 2019-06-21T16:29:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-via-libera-a-vyleesi-il-viagra-femminile/ 2019-06-24T12:54:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-italia-soren-giese-nuovo-presidente-e-ad/ 2019-06-24T13:13:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-sceglie-il-gaming-per-parlare-di-genetica-dei-tumori/ 2019-06-24T14:32:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-dupixent-candidato-asma-inferiore-a-dupixent/ 2019-06-24T17:51:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-ecco-i-vincitori-della-borsa-di-studio-bvdzero/ 2019-06-24T15:20:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-accordo-con-nurxi-per-sviluppo-antitumorali/ 2019-06-24T16:01:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bristol-myers-celgene-verso-la-cessione-di-apremilast/ 2019-06-25T17:38:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-fda-accetta-priority-review-per-zejula/ 2019-06-25T14:20:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pasteur-aifa-estende-vaxigrip-tetra-alle-donne-in-gravidanza/ 2019-06-25T15:06:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2019-anno-di-farmaci-biologici-e-contro-le-malattie-rare/ 2019-06-25T15:28:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ancora-un-megamerger-abbvie-acquisisce-allergan/ 2019-06-25T16:40:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/krystal-impegnata-nella-epidermolisi-bollosa/ 2019-06-25T16:44:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-nasce-nuovo-player-assicurativo/ 2019-06-26T13:22:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-salute-un-mercato-da-4-trilioni-di-dollari/ 2019-06-26T13:17:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-cede-stabilimento-colorado-a-produttore-cbd/ 2019-06-26T13:42:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-acquisisce-i-diritti-di-lebrikizumab/ 2019-06-26T16:02:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-le-perplessita-degli-investitori/ 2019-06-26T15:16:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-massimo-visentin-confermato-presidente-del-gruppo-prevenzione/ 2019-06-26T15:31:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-ok-fda-a-dupixent-nella-rinosinusite-cronica-con-polipi-nasali/ 2019-06-27T18:09:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/acqusizioni-ora-a-chi-tocca/ 2019-06-28T13:40:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-chan-zuckerberg-altri-60-mln-di-dollari-per-human-cell-atlas/ 2019-06-27T18:20:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parkinson-le-start-up-seguono-la-via-dellintestino/ 2019-06-27T19:17:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/encoded-104-mln-di-dollari-per-la-sindrome-di-dravet/ 2019-06-27T18:55:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-a-tamara-diol-la-direzione-delle-hr/ 2019-07-01T16:05:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jazz-pharmaceuticals-focus-a-milano-sulla-lma/ 2020-11-10T09:15:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-acquista-impianto-per-prodotti-sterili-da-novartis/ 2019-07-01T14:14:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-chmp-per-atezolizumab-nel-tumore-al-seno-triplo-negativo-metastatico/ 2019-07-01T14:27:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mariapia-garavaglia-fondazione-roche-il-paziente-al-centro/ 2019-07-01T14:54:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-per-dupixent-negli-adolescenti-con-da-parere-positivo-del-chmp/ 2019-07-01T15:35:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bracco-imaging-acquisisce-blue-earth-diagnostics/ 2019-07-02T16:22:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-gottlieb-entra-nel-cda/ 2019-07-02T16:25:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-premia-i-campioni-del-fair-play/ 2019-07-02T16:40:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-un-futuro-trasparente/ 2019-07-02T16:52:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amicus-operazione-cdmo-con-thermo-fischer/ 2019-07-02T17:10:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomedicale-this-is-the-future-per-la-medical-valley-italiana/ 2019-07-02T19:31:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-ok-fda-a-soliris-nei-pazienti-con-nmsod/ 2019-07-03T13:34:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-si-del-nice-a-libtayo/ 2019-07-03T13:52:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-accordo-con-azienda-coreana-per-farmaco-nash/ 2019-07-03T14:04:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biovac-institute-produrra-per-il-sudafrica-vaccini-sanofi-e-pfizer/ 2019-07-03T14:20:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-genzyme-tredici-finalisti-per-research-to-care/ 2019-07-03T15:02:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-ok-europeo-a-dolutegravir-lamivudina/ 2019-07-03T16:16:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-health-annunci-di-farmaci-sullo-smartphone-mentre-si-aspetta-il-medico/ 2019-07-04T14:02:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carenze-farmaci-la-rassicurazione-di-aifa/ 2019-07-04T14:09:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-ce-autorizza-cemiplimab/ 2019-07-04T16:41:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sprycel-bms-interruttore-on-off-delle-cellule-car-t/ 2019-07-04T15:30:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-ottimi-dati-dallo-studio-nurture/ 2019-07-04T16:29:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-scaccabarozzi-pronti-a-dialogare-per-nuova-governance/ 2019-07-04T17:01:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-nuovo-farmaco-contro-mieloma-multiplo/ 2019-07-05T13:40:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-xofluza-efficace-quanto-tamiflu/ 2019-07-05T13:57:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fake-news-salute-facebook-entra-in-campo/ 2019-07-05T17:28:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-emofilia-nuovi-dati-su-damoctocog-alfa-pegol/ 2019-07-05T14:45:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-frontline-brand-dellanno-nei-world-branding-award/ 2019-07-05T14:44:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-modifica-del-gene-crispr-possibile-nuovo-target-terapeutico/ 2019-07-05T15:19:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-hiv-nuovi-dati-positivi-su-dovato/ 2019-07-10T14:14:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibs-c-alfasigma-acquisisce-tegaserod-per-la-reintroduzione-nel-mercato-statunitense/ 2019-07-10T15:24:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-sangamo-buoni-risultati-per-la-terapia-contro-lemofilia-a/ 2019-07-10T14:25:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-animal-health-ce-anche-elanco/ 2019-07-10T14:43:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-ancora-dati-su-sicurezza-ed-efficacia-di-minimed-640g/ 2019-07-10T14:56:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuove-evidenze-per-emicizumab-nellemofilia-a/ 2019-07-10T15:22:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-fda-a-revisione-isatuximab/ 2019-07-11T13:21:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-una-campagna-per-realizzare-i-sogni-di-chi-soffre-di-emoficlia/ 2019-07-11T13:56:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-accordo-con-celsius-therapeutics-per-nuove-terapie-ibd/ 2019-07-11T14:37:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amazon-sbarca-nellnhs-con-alexa/ 2019-07-11T15:01:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-chiesi-trend-positivo-anche-nel-2019/ 2019-07-11T15:19:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-verso-nuovi-criteri-di-valutazione/ 2019-07-11T15:49:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-sempre-piu-trasparente/ 2020-11-10T09:11:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-punta-sullai-e-prende-un-super-esperto/ 2019-07-12T13:44:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-sempre-piu-testa-a-testa-tra-gilead-e-gsk/ 2019-07-12T15:48:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-pharma-il-nuovo-ceo-e-christi-shaw/ 2020-11-10T09:01:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-pharma-italy-ok-ce-a-ravulizumab-nella-epn/ 2019-07-12T15:11:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-car-t-nuova-strada-per-i-tumori-solidi/ 2019-07-12T15:08:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-italia-il-well-being-si-chiama-liberamente/ 2019-07-15T13:38:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-accordo-miliardario-con-galapagos/ 2019-07-15T13:37:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-ok-fda-alla-nuova-linea-alinity/ 2019-07-15T13:52:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-sperimentazione-vaccino-hiv-in-europa-e-usa/ 2019-07-15T14:12:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-jonathan-symonds-nuovo-presidente/ 2019-07-15T14:56:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-falsificati-aifa-in-italia-nessuna-segnalazione/ 2019-07-15T16:02:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-81-opere-in-gara-per-il-premio-leggi-in-salute-angelo-zanibelli/ 2019-07-16T13:24:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/caso-avastinlucentis-consiglio-di-stato-conferma-sanzioni-a-roche-e-novartis/ 2019-07-16T13:50:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-lascesa-di-skyrizi/ 2019-07-16T14:07:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-su-biotech-svizzera-per-vaccini-oncologici/ 2019-07-16T14:42:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-cede-tre-farmaci-a-recordati/ 2019-07-16T15:01:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-utili-alle-stelle-nel-q2/ 2019-07-16T15:51:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-revisione-fda-prioritaria-per-crizanlizumab/ 2019-07-17T13:50:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-aumenta-la-produzione-di-freestyle-libre/ 2019-07-17T14:02:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-per-stelara-darzaelx-e-tremfya-crescita-a-due-cifre/ 2019-07-17T14:16:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-pharma-nuova-struttura-per-vettori-virali-delle-terapie-geniche/ 2019-07-17T14:36:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/karyopharm-per-xpovio-un-futuro-nel-glioblastoma/ 2019-07-17T15:04:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shionogi-verso-lautonomia-commerciale-negli-usa/ 2019-07-17T15:29:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-in-europa-o-asia-la-vendita-degli-otc/ 2019-07-18T14:05:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-stime-in-rialzo-grazie-a-sandoz/ 2019-07-18T13:57:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-labs-azioni-al-massimo-storico-nel-q2/ 2019-07-18T15:58:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ok-fda-a-combo-antibotici-recabrio/ 2019-07-18T14:36:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/paragon-biosciences-ai-per-diagnosi-cancro-alla-mammella/ 2019-07-18T15:06:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-e-india-prove-tecniche-di-alleanza-nel-pharma/ 2019-07-18T15:29:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-accordo-con-azienda-coreana-per-candidato-ipf/ 2019-07-19T14:21:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/seqirus-a-siena-la-nuova-sede-italiana/ 2019-07-19T14:38:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cannabis-medica-nuovo-accordo-tra-aurora-e-governo-italiano/ 2019-07-19T14:47:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-la-cina-dice-si-a-gilenya/ 2019-07-19T14:54:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-bayer-collaborazione-per-opdivo-e-stivarga/ 2019-07-19T15:52:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zolgensma-per-vas-narasimhan-un-lancio-di-grande-successo/ 2019-07-19T15:56:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-vendite-oltre-le-aspettative-nel-q2/ 2019-07-22T14:21:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-acquista-da-novartis-tre-antivirali/ 2019-07-22T14:28:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-offensiva-usa-dei-biosimilari/ 2019-07-22T14:46:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nash-una-scoperta-apre-nuove-prospettive/ 2019-07-22T15:12:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/negli-usa-i-farmaci-si-riciclano-con-google-maps/ 2019-07-22T15:25:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-italia-al-via-ledizione-2019-de-il-battito-del-cuore/ 2019-07-22T16:03:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-il-marchio-dr-scholl-a-societa-dinvestimento-privata-usa/ 2019-07-23T13:26:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-sanofi-i-diritti-usa-di-tamiflu/ 2019-07-23T13:25:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-ok-fda-a-otezla-nella-malattia-di-behcet/ 2019-07-23T13:42:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-prima-nellitaly-pharma-reptrak-2019/ 2019-07-23T13:53:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cochlear-italia-2000-pazienti-sordi-assistiti-nel-2018/ 2019-07-23T14:19:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-accordo-con-innovation-pharmaceuticals-per-brilacidin/ 2019-07-23T14:35:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/simg-ad-aifa-coinvolgeteci-nel-rapporto-osmed/ 2019-07-23T15:12:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ok-fda-ad-hadlima-biosimilare-di-humira/ 2019-07-24T17:08:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-tecfidera-guida-la-crescita-nel-q2/ 2019-07-24T14:19:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-alleanza-mondiale-contro-il-cancro-al-polmone/ 2019-07-24T14:43:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emergenza-ebola-in-campo-anche-il-vaccino-di-johnson/ 2019-07-24T15:18:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-quattro-lanci-di-nuovi-farmaci-negli-usa/ 2019-07-24T16:21:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ingegneria-clinica-a-roma-a-ottobre-il-congresso-mondiale/ 2019-07-24T16:04:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zambon-grande-colpo-per-la-pipeline-presa-breath-therapeutics/ 2019-07-25T13:04:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-ok-fda-a-baqsimi-prima-terapia-inalabile-per-lipoglicemia-graave/ 2019-07-25T13:33:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/healthcare-ecco-i-leader-che-guidano-linnovazione/ 2019-07-25T14:02:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-novita-sugli-agonisti-tlr7-vesatolimod-nellhiv/ 2019-07-25T14:29:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-nellhiv-regime-a-2-farmaci-efficace-come-il-taf/ 2019-07-25T15:06:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzo-spinraza-la-replica-di-biogen/ 2019-07-25T15:25:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-q2-con-tagrisso-al-top/ 2019-07-26T11:09:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-q2-ottimo-e-aumentano-previsioni-sugli-utili/ 2019-07-26T13:03:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-allergan-il-merger-che-piace-agli-analisti/ 2019-07-26T14:09:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-continua-la-sua-espansione-nel-cdmo/ 2019-07-26T14:39:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-nuove-evidenze-per-i-fattori-a-emivita-prolungata-nellemofilia/ 2019-07-26T15:16:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/modelli-3d-parkinson-e-sm-sulla-stazione-spaziale-internazionale/ 2019-07-26T16:24:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vas-narasimhan-novartis-non-vende-sandoz/ 2019-07-29T13:33:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-ok-chmp-a-vitrakvi/ 2019-07-29T13:43:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-mylan-un-merge-per-i-farmaci-off-patent/ 2019-07-30T08:15:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-dupixent-mette-il-turbo-al-q2/ 2019-07-29T15:11:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-resiste-allassalto-dei-biosimilari-grazie-a-shingrix-e-nucala/ 2019-07-29T15:46:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-ritira-dal-mercato-espansori-e-protesi-mammarie-biocell/ 2019-07-29T16:03:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fresenius-aumenta-le-stime-per-il-2019/ 2019-07-30T13:28:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/test-oncologici-acquisto-miliardario-per-exact-sciences/ 2019-07-30T13:46:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-in-alto-gli-utili-trimestrali/ 2019-07-30T14:00:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-frenata-sugli-obiettivi-2019/ 2019-07-30T15:05:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-skyrizi-outstanding/ 2019-07-30T15:39:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-editas-medicine-parte-sperimentazione-sulluomo-candidato-crispr/ 2019-07-30T16:18:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-rapporto-vaccini-2018-sicurezza-confermata/ 2019-07-30T16:35:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-i-nuovi-farmaci-fanno-salire-le-previsioni-sugli-utili-2019/ 2019-07-31T13:24:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-orion-ok-fda-a-darolutamide-nel-cancro-alla-prostata/ 2019-07-31T13:44:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-q2-positivo-nonostante-contrazione-delle-entrate/ 2019-07-31T14:17:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-volano-gli-utili/ 2019-07-31T14:48:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/smith-nephew-cresce-nei-paesi-emergenti/ 2019-07-31T15:12:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-revlimid-e-pomalyst-superstar-del-q2/ 2019-07-31T16:06:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-nel-q2-brilla-symkevi-farmaco-contro-la-fibrosi-cistica/ 2019-08-01T14:16:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-accordo-con-inglese-sensyne-health-per-accedere-a-dati-sanitari/ 2019-08-01T15:55:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/start-up-9-mln-a-prellis-per-tessuti-3d/ 2019-08-01T14:46:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/indivior-crescono-gli-utili/ 2019-08-01T15:06:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-spark-ancora-un-rinvio-per-il-closing/ 2019-08-01T15:29:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/podcast-e-radio-streaming-la-nuova-frontiera-della-comunicazione-pharma/ 2019-08-01T15:52:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-anche-eisai-e-sysmex-al-lavoro-su-test-del-sangue/ 2019-08-02T13:24:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leo-pharma-catherine-mazzacco-nuovo-amministratore-delegato/ 2019-08-05T07:19:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-johnson-efficace-iniezione-bimestrale-combo-antihiv/ 2019-08-26T10:22:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-buoni-risultati-per-terapia-sperimentale-contro-mm/ 2019-08-26T10:48:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-da-hhs-usa-23-mln-dollari-per-vaccino-sperimentale-ebola/ 2019-08-26T13:00:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/outcome-nuovo-imperativo-delle-pharma/ 2019-08-26T15:12:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-alexion-merger-prossimo-venturo/ 2019-08-26T15:36:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/effetto-brexit-ian-hudson-lascia-la-mhra/ 2019-08-26T17:16:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-spesa-monstre-per-assicurarsi-otezla-di-celgene/ 2019-08-27T10:14:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-fast-track-fda-per-farxiga-nellinsufficienza-cardiaca-e-renale/ 2019-08-27T10:32:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-nelle-farmacie-usa-la-versione-generica-pediatrica-di-epipen/ 2019-08-27T10:45:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-500-mln-di-dollari-nella-produzione-di-terapie-geniche/ 2019-08-27T12:46:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-e-pfizer-attesa-per-xtandi-in-priority-review/ 2019-08-27T15:08:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alcon-crescono-le-vendite-nel-q2/ 2019-08-27T15:21:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fresenius-e-una-manager-takeda-il-nuovo-cfo/ 2019-08-28T16:47:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-per-fasenra-status-di-orphan-drug-da-fda/ 2019-08-28T13:58:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-e-biotech-il-valzer-delle-poltrone/ 2020-11-10T08:55:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-lavori-in-corso/ 2019-08-28T15:10:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adv-pharma-verso-il-digitale-e-lora-dello-shift/ 2019-08-28T15:36:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ad-elanco-i-farmaci-veterinari-di-bayer/ 2019-08-28T16:01:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-cosmed-annunciano-partnership-per-q-negdispositivo-di-monitoraggio-metabolico/ 2019-08-29T09:55:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-dopo-otto-anni-lascia-il-ceo-ishrak/ 2020-11-10T09:01:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rohe-ok-europeo-a-tecentriq/ 2019-08-29T15:03:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-anifrolumab-centra-obiettivo-studio/ 2019-08-29T15:07:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-acquisisce-due-prodotti-sanofi-healthcare/ 2019-08-29T15:18:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-partnership-con-immatics-per-terapie-cellulari/ 2019-08-29T15:37:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-fda-concede-la-tentative-approval-al-generico-di-alimta/ 2019-08-30T16:23:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-novita-al-congresso-esc/ 2019-08-30T13:35:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/olympus-sony-cede-meta-della-sua-quota-azionaria/ 2019-08-30T14:29:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sm-prezzi-farmaci-ancora-troppo-alti/ 2019-08-30T15:07:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/glioblastoma-una-risposta-dalle-nanoterapie/ 2019-08-30T15:40:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-da-ce-ok-a-tripletta-mieloma-multiplo-recidivo-e-refrattario/ 2019-08-30T16:12:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fidia-da-novartis-farma-spagna-tre-prodotti-per-loftalmologia/ 2019-09-02T13:54:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-bms-allesc-i-dati-real-world-di-eliquis/ 2019-09-02T14:12:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-buoni-risultati-per-ofatumumab-nella-sm/ 2019-09-02T14:40:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-ce-ad-atezolizumab-con-chemioterapia-prima-linea-nel-mtnbc/ 2019-09-02T15:13:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viela-bio-la-spinout-di-astrazeneca-che-sfida-i-colossi/ 2019-09-02T16:09:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-lixiana-efficace-e-sicuro-nella-fanv/ 2019-09-02T16:08:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-no-deal-prima-fuga-di-pharma-britannica/ 2019-09-03T13:23:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-cambiano-le-gare-di-appalto/ 2019-09-03T13:40:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ceo-le-startup-della-borsa-di-hong-kong-pagano-meglio/ 2019-09-03T14:20:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-genzyme-italia-il-nuovo-gm-e-marcello-cattani/ 2019-09-03T14:41:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-opdivo-meglio-della-chemio-per-la-sopravvivenza-nel-nsclc/ 2019-09-03T15:17:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obesita-e-diabete-ce-una-via-genetica-per-la-terapia/ 2019-09-03T15:44:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-e-sandoz-mossa-svizzera-per-i-biosimilari/ 2019-09-04T13:39:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-della-cina-a-tagrisso-nel-tumore-del-polmone/ 2019-09-04T13:48:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-acquisisce-semma-therapeutics-per-espandersi-nel-diabete/ 2019-09-04T14:08:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-arriva-super-manager-per-il-business-development/ 2019-09-04T14:46:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-spark-ancora-un-rinvio/ 2019-09-04T16:48:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovo-governo-roberto-speranza-al-dicastero-della-salute/ 2019-09-04T16:09:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-cominciata-lera-paul-hudson/ 2019-09-05T13:58:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-accordo-con-biomotiv-per-accelerare-le-biotecnologie/ 2019-09-05T14:10:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-per-luxturna-ce-lok-del-nice/ 2019-09-05T14:36:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dm-auguri-al-neo-ministro-molte-le-sfide-aperte/ 2019-09-05T15:05:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premio-arrigo-recordati-ad-alberto-auricchio-coordinatore-del-tigem/ 2019-09-05T15:35:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-usa-reputazione-ai-minimi-storici-fra-i-consumatori/ 2019-09-05T16:08:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/facebook-impegno-per-informazioni-corrette-sui-vaccini/ 2019-09-06T13:29:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-il-giappone-investe-in-svizzera/ 2019-09-06T13:45:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-breakthroug-therapy-da-fda-per-capmatinib/ 2019-09-06T13:54:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-e-pharma-alleate-per-i-test-di-sequenziamento-genico/ 2019-09-06T14:32:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-corsa-a-tre-ma-sharpless-e-favorito/ 2019-09-06T15:05:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/twitter-il-verticale-della-salute-oltre-i-280-caratteri/ 2019-09-06T15:44:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-ok-fda-a-ofev-nella-pneumopatia-interstiziale/ 2019-09-09T13:16:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/walgreens-arriva-il-top-manager-digitale/ 2020-11-10T09:12:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stryker-si-espande-nella-chirurgia-della-colonna-vertebrale/ 2019-09-09T16:03:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-punta-su-forxiga-e-amplia-la-forza-vendite/ 2019-09-09T15:04:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-parla-il-ceo-schwan-niente-acquisizioni-pipeline-robusta/ 2020-11-10T08:59:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-arriva-il-manager-per-la-centralita-del-paziente/ 2020-11-10T08:25:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-campoverde-di-aprilia-sempre-piu-hub-del-futuro/ 2019-09-10T13:29:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-tecentriq-avanza-in-europa/ 2019-09-10T14:13:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-efficace-candidato-tumori-polmonari-con-anomalia-gene-ret/ 2019-09-10T15:17:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-ottimi-risultati-per-candidato-nsclc-con-mutazione-gene-kras/ 2019-09-10T16:00:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-una-speranza-viene-dalla-slovacchia/ 2019-09-10T16:27:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-del-nice-a-risankizumab-per-la-psoriasi-a-placche-negli-adulti/ 2019-09-10T17:11:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/imfinzi-ancora-risultati-positivi/ 2019-09-11T13:18:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-data-ai-e-servizi-cloud-accordo-google-mayo-clinic/ 2019-09-11T13:27:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-nuovi-dati-per-spravato-nel-disturbo-depressivo-maggiore/ 2019-09-11T13:45:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-mette-a-punto-il-successore-di-prevnar-13/ 2019-09-11T14:18:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-rescinde-laccordo-con-lexicon-per-zynquista/ 2019-09-11T14:38:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-sempre-piu-ocrevus-nella-sm/ 2019-09-11T15:07:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-sclerosi-multipla-ozanimod-riduce-le-ricadute/ 2019-09-12T14:40:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-con-sitari-punta-alla-terapia-per-la-celiachia/ 2019-09-12T14:47:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kggaa-breakthrough-therapy-per-tepotinib-nel-tumore-al-polmone/ 2019-09-12T14:56:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apple-alle-ricerca-di-big-data-con-tre-studi/ 2019-09-12T15:15:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-10-anni-di-tecfidera-per-guardare-al-futuro-della-sm/ 2019-09-12T16:58:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jazz-pharmaceuticals-da-aifa-innovazione-terapeutica-per-vyxeos-nella-lma/ 2019-09-13T10:56:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-parte-dalla-grecia-la-rivoluzione-digitale/ 2019-09-13T13:47:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-al-via-trial-clinico-su-dispositivo-riparazione-valvola-tricuspide/ 2019-09-13T13:57:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-buoni-risultati-preliminari-per-vaccini-a-mrna/ 2019-09-13T14:15:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nella-spms-mayzent-ritarda-di-4-anni-luso-della-sedia-a-rotelle/ 2019-09-13T14:37:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aspen-ok-fda-a-farmaco-che-previene-parti-pretermine/ 2019-09-13T15:14:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fibrosi-cardiaca-la-cureremo-con-le-cart/ 2019-09-13T15:41:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-priority-review-per-farxiga/ 2019-09-16T14:22:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-e-sanofi-per-la-digitalizzazione-del-diabete/ 2019-09-16T14:28:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-compra-alder-ed-entra-nel-campo-dellemicrania/ 2019-09-16T14:49:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ocrevus-sempre-piu-leader-nella-sm/ 2019-09-16T15:42:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-mirikizumab-efficace-nella-colite-ulcerosa/ 2019-09-16T16:15:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-ottimi-risultati-per-mavenclad-nel-clarity-extension/ 2019-09-16T16:37:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-e-medtronic-sinergia-per-il-diabete/ 2019-09-17T14:19:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-ai-per-gestire-lassistenza-clienti/ 2019-09-17T14:39:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sumitomo-dainippon-efficace-il-cerotto-alla-blonanserina-nella-schizofrenia/ 2019-09-17T14:53:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-johnson-alleanza-contro-il-mieloma-multiplo/ 2019-09-17T15:39:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fresenius-no-alla-vendita-dellunita-trasfusione-di-sangue/ 2019-09-17T15:43:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharmanutra-primo-semestre-2019-a-doppia-cifra/ 2019-09-17T15:52:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-chiave-per-una-leadership-di-successo-e-linnovazione-intervista-a-luca-crippa-ceo-di-ibsa-italia/ 2020-11-10T08:59:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-una-app-per-trattare-la-depressione-nella-sm/ 2019-09-18T12:49:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-si-difende-dallattacco-dei-generici-dellhcv/ 2019-09-18T13:16:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-nuovi-dati-positivi-per-ozempic/ 2019-09-18T13:42:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-breakthrough-therapy-per-gazyva-nella-nefrite-da-lupus/ 2019-09-18T15:01:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-allarme-fornitura-insulina/ 2019-09-18T15:42:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-polmone-tripletta-aumenta-efficacia-inibitori-kras/ 2019-09-19T13:35:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/consorzio-internazionale-acquista-china-biologic/ 2019-09-19T13:54:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cladribina-confermate-lefficacia-e-la-sicurezza-a-lungo-termine/ 2019-09-19T14:15:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-ok-fda-a-spray-alla-nicotina-come-otc/ 2019-09-19T14:06:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-carica-biosim-in-usa-battaglia-aspra-ma-la-pipeline-terra/ 2019-09-19T14:52:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-manufacturing-2030-manifesto-per-la-leadership-italiana-nel-settore/ 2019-09-19T16:39:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-efficacia-di-cemiplimab-nel-cscc/ 2019-09-20T08:50:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lintervista-un-nuovo-paradigma-per-lo-sviluppo-di-farmaci/ 2019-09-20T13:02:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/e-lora-del-farmaco-veterinario/ 2019-09-20T15:44:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-al-via-due-studi-fase-3-per-valutare-efficacia-di-evobrutinib-nellaa-smr/ 2019-09-20T14:35:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-raddoppia-gli-sforzi-per-le-terapie-geniche/ 2019-09-20T15:10:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/plos-medicine-in-europa-molte-approvazioni-accelerate-basate-su-endpoint-surrogati/ 2019-09-20T15:37:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-disco-verde-fda-a-rybelsus-semaglutide-orale/ 2019-09-24T06:59:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-nuovo-trial-clinico-su-spinraza-a-dosaggio-piu-elevato/ 2019-09-23T14:22:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-per-i-medical-device-un-nuovo-step/ 2019-09-23T14:38:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-emma-walmsley-nel-cda-di-microsoft/ 2019-09-23T15:02:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-tutto-pronto-per-il-bhap-2019/ 2019-09-23T15:43:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-ok-chmp-a-uso-interferone-beta-1-a-in-gravidanza/ 2019-09-23T16:00:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-eisai-progetto-orbis-ok-a-combo-keytruda-lenvima/ 2019-09-24T13:25:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-rybelsus-cambiera-il-mercato-del-diabete/ 2019-09-24T13:42:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/appello-oms-ai-governi-aumentare-la-spesa-sanitaria/ 2019-09-24T17:01:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-italia-rinnova-limpegno-per-la-diversita-e-linclusione/ 2019-09-24T14:31:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epigenoma-nuova-tecnica-crispr-fa-ben-sperare-la-ricerca-biomedica/ 2019-09-24T14:53:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/deal-parola-dordine-dei-ceo-usa/ 2020-11-10T08:59:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/blockbuster-quattro-in-rampa-di-lancio/ 2019-09-25T14:06:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibm-watson-health-accordo-con-guerbet-per-sfruttare-ai-nel-cancro-della-prostata/ 2019-09-25T14:15:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bavarian-nordic-ok-fda-a-vaccino-contro-monkeypox/ 2019-09-25T14:23:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/clovis-oncology-passa-ai-radiofarmaci/ 2019-09-25T14:51:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-celebra-cinque-anni-di-keytruda/ 2019-09-25T15:13:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nuovi-dati-di-efficacia-per-cosentyx/ 2019-09-25T16:20:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-via-libera-fda-a-test-infarto-altamente-sensibile/ 2019-09-26T13:57:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-del-sangue-nuovo-target-per-terapie-car-t/ 2019-09-26T14:33:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-arriva-hugo-il-robot-per-la-chirurgia-dei-tessuti-molli/ 2019-09-26T14:30:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-chmp-a-dupilumab-nella-crswnp/ 2019-09-26T15:06:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gare-di-appalto-in-cina-arrivano-le-pharma-occidentali/ 2019-09-26T15:41:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-nuovo-impianto-di-produzione-in-usa/ 2019-09-26T15:57:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nitrosammine-nei-farmaci-aifa-chiarisce/ 2019-09-27T08:02:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ipoglicemia-e-famiglia-al-centro-della-comunicazione/ 2019-09-27T14:02:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-studio-varsity-vedolizumab-superiore-ad-adalimumab/ 2020-11-10T09:11:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-linee-guida-per-luso-dellai/ 2019-09-27T16:01:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/esmo-2019-roche-bene-atezolizumab-in-monoterapia-nel-tumore-al-polmone/ 2019-09-28T12:38:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/esmo-2019tumore-dellovaio-novita-sugli-inibitori-parp/ 2019-09-29T10:33:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-italia-chiara-rocchetti-direttrice-comunicazione-e-public-affairs/ 2019-09-30T09:11:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/esmo-2019-roche-dallo-studio-bfast-grande-risposta-ad-alecitinib/ 2019-09-30T14:34:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/esmo-2019-tumore-del-seno-migliora-la-sopravvivenza-con-terapie-di-combinazione/ 2019-09-30T14:24:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/esmo-2019-roche-atezolizumab-e-chemio-efficaci-in-prima-linea-nel-tumore-prostata/ 2019-10-02T09:56:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-triplice-combo-per-il-ccr/ 2019-09-30T16:22:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/esmo-2019-il-sequenziamento-di-nuova-generazione-del-dna/ 2019-09-30T16:36:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-sceglie-microsoft-per-la-rivoluzione-digitale/ 2019-10-01T15:19:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-alla-tedesca-cheplapharm-i-diritti-su-losec/ 2019-10-02T13:30:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-bene-recabrio-anche-nella-polmonite-baterica/ 2019-10-02T13:54:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-le-prime-indicazioni-del-nuovo-ceo-hudson/ 2020-11-10T08:59:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-i-prossimi-passi-per-ofev/ 2020-11-10T08:55:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/esmo-2019-un-congresso-di-grande-valore/ 2019-10-02T15:37:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-italia-adelaide-raia-a-capo-della-bu-consumer-pharma-care/ 2020-11-10T08:55:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-talz-ottiene-la-rimborsabilita-ssn-nellartrite-psoriasica/ 2019-10-04T07:46:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-zerbaxa-sicuro-ed-efficace-nella-polmonite-nosocomiale/ 2019-10-03T13:31:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-allarme-impurita-per-i-farmaci-contenenti-ranitidina-ma-occhio-ai-test/ 2019-10-03T13:54:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pasteur-premia-la-comunicazione-scientifica-ed-efficace-sui-vaccini/ 2019-10-03T16:57:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/discovery-drug-ce-anche-la-britannica-c4x/ 2019-10-03T15:25:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-un-ex-commissario-fda-per-rilanciare-alphabet/ 2019-10-03T16:09:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-fda-ad-auto-somministrazione-di-fasenra/ 2019-10-04T12:54:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotici-dal-mit-virus-batteriofagi-ingegnerizzati/ 2019-10-04T13:40:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-hiv-fda-approva-descovy-come-prep/ 2019-10-04T14:21:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-presto-nuova-indicazione-per-cosentyx/ 2019-10-04T14:33:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-dura-stoccata-a-big-pharma-usa/ 2019-10-04T15:17:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rapporto-aifa-tornano-a-crescere-le-sperimentazioni-cliniche-in-italia/ 2019-10-04T16:08:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nobel-per-la-medicina-2019-a-william-kaelin-peter-ratcliffe-e-gregg-semenza/ 2019-10-07T15:39:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-accordo-con-prometheus-per-farmaci-anti-ibd/ 2019-10-07T13:55:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-emma-walmsley-per-la-parita-salariale-tra-uomini-e-donne/ 2019-10-07T14:05:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-quale-sara-la-top-ten-del-2025/ 2019-10-08T11:06:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-500-mln-di-dollari-per-eliminare-hiv-e-tubercolosi/ 2019-10-07T15:56:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carcinoma-prostata-zejula-e-lynparza-allesame-fda/ 2019-10-07T16:28:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-lancia-campagna-social-sul-tumore-colorettale/ 2020-11-10T08:25:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-nuove-evidenze-per-cyramza-in-combo-con-terceva-roche-nel-nsclc/ 2019-10-08T16:56:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boston-pharmaceuticals-al-via-studio-su-candidato-carcinoma-mammario-triplo-negativo/ 2019-10-08T15:08:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/informatori-e-doctor-web-chi-bussa-alla-porta-del-medico/ 2019-10-08T17:26:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-fda-a-beovu-nella-degenerazione-maculare-senile-umida/ 2019-10-08T16:25:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-akcea-accordo-per-sviluppare-terapia-antisenso-nel-cardiometabolico/ 2019-10-08T16:47:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-mega-risarcimento-da-8-mld-di-dollari-per-effetti-collaterali-risperdal/ 2019-10-09T14:13:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-genzyme-ecco-gli-otto-finalisti-di-make-to-care/ 2019-10-11T09:52:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-ritira-zantac-dal-mercato-a-scopo-precauzionale/ 2019-10-09T15:44:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-per-chmp-interferone-beta-1b-sicuro-nelle-donne-con-sm-in-gravidanza/ 2019-10-09T16:11:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-accordo-con-4d-pharma-per-sviluppo-vaccini/ 2019-10-09T16:17:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/galderma-arrivano-da-shire-i-nuovi-ceo-e-cfo/ 2020-11-10T08:59:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ecco-i-vincitori-del-premio-zanibelli-2019/ 2019-10-10T14:26:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-accordo-di-ricerca-con-il-giapponese-riken-innovation/ 2019-10-10T14:54:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-acquisisce-ra-pharmaceuticals/ 2019-10-10T15:06:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-per-dovato-campagna-adv-real-world-negli-usa/ 2019-10-10T15:26:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-bluebird-bio-per-ampliare-la-pipeline-nellemofilia/ 2019-10-10T15:52:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-sempre-piu-attiva-in-uk/ 2019-10-10T16:13:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-partnership-con-lyall-immunopharma-per-le-cellule-t/ 2019-10-11T14:03:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-usa-il-rapporto-dellicer/ 2019-10-11T14:25:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ginkgo-bioworks-un-fondo-per-creare-spinout/ 2019-10-11T14:50:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomarin-un-manager-per-le-malattie-rare/ 2019-10-11T15:37:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viagra-un-futuro-nei-trapianti-di-cellule-staminali-ematopietiche/ 2019-10-11T15:35:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-nuova-frontiera-del-mkt-farmaceutico-leffetto-pasticceria/ 2019-10-11T16:06:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nuovo-quartier-generale-in-uk/ 2019-10-14T10:17:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ebola-in-congo-arriva-il-vaccino-johnson/ 2019-10-14T12:29:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-molto-bene-abrocitinib-in-fase-3/ 2019-10-14T12:56:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-combinazione-farmaci-asma-vicina-ad-approvazione/ 2019-10-14T13:24:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-disco-verde-fda-a-reyvow-nellemicrania/ 2019-10-14T13:41:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-studio-individua-come-lrna-resiste-ai-retrovirus/ 2019-10-14T16:01:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-una-mostra-per-raccontare-limmunologia/ 2019-10-15T16:09:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-nivolumab-migliora-la-sopravvivenza-nel-carcinoma-esofageo-in-fase-avanzata/ 2019-10-15T14:59:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-accordi-con-11-start-up-nellambito-del-programma-g4a/ 2019-10-15T14:57:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-alla-svizzera-acino-il-portfolio-per-mo-e-africa/ 2019-10-15T15:11:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-autoimmuni-buone-prospettive-dalle-car-t-utilizzate-come-esca/ 2019-10-15T16:11:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/3m-allarga-la-propria-offerta-con-lacquisizione-di-acelity/ 2019-10-15T16:18:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-nuova-piattaforma-per-la-supply-chain/ 2019-10-16T14:10:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-aumenta-le-stime-di-vendita-per-il-2019/ 2019-10-17T13:14:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-fda-a-revisione-prioritaria-per-trastuzumab-deruxtecan/ 2019-10-17T13:32:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-genzyme-vincono-make-to-care-2019-due-progetti-per-disabilita-visive/ 2019-10-17T13:50:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-labs-sofferenze-nel-cardiovascolare-q3-sotto-le-stime/ 2019-10-17T15:40:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-partnership-con-spencer-health-solutions-per-aderenza-terapie/ 2019-10-17T15:17:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/seqirus-arriva-in-italia-vaccino-quadrivalente-sviluppato-su-coltura-cellulare/ 2019-10-17T15:31:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-domenico-mantoan-e-il-nuovo-presidente/ 2020-11-10T08:54:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-si-espande-con-achillion-nelle-malattie-rare/ 2019-10-18T13:07:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-del-chmp-a-rinvoq-nellartrite-reumatoide/ 2019-10-18T13:23:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-roche-tumore-dellovaio-bene-combo-nivolumab-bevacizumab/ 2019-10-18T13:57:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tandem-diabetes-care-funziona-il-pancreas-artificiale/ 2019-10-18T15:14:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-bms-insieme-per-rilevare-aritmie-cardiache-con-gli-smartwatch-di-fitbit/ 2019-10-18T16:16:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/patients-digital-health-award-i-premiati-della-seconda-edizione/ 2020-11-10T08:24:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnsonok-chmp-a-spravato-antidepressivo-spray/ 2019-10-21T10:42:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-a-bavarian-nordik-due-vaccini-antirabbici/ 2019-10-21T17:26:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-fda-estende-uso-di-ultomiris/ 2019-10-21T16:10:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-da-cinque-societa-scientifiche-no-alla-sostituibilita-automatica/ 2019-10-21T14:12:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-epatocarcinoma-combo-tecentiq-avastin-prolunga-sopravvivenza/ 2019-10-21T15:09:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/smith-nephew-lascia-il-ceo-in-arrivo-ex-roche-diagnostics/ 2020-11-10T08:59:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-ok-fda-a-trikafta-nella-fibrosi-cistica/ 2019-10-22T14:00:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-farxiga-per-linsufficienza-cardiaca-ce-lok-della-fda/ 2019-10-22T14:19:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-avanti-tutta-su-aducanumab-nella-malattia-di-alzheimer/ 2019-10-22T15:48:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ok-chmp-per-vaccino-contro-ebola-e-oms-applaude/ 2019-10-22T16:18:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-stelara-efficace-nella-colite-ulcerosa-moderata-e-grave/ 2019-10-22T16:33:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-q3-allinsegna-di-cosentyx-e-zolgensma/ 2019-10-24T14:32:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-quinto-trimestre-consecutivo-di-crescita/ 2019-10-25T15:17:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-fda-approva-estensione-di-zejula/ 2019-10-24T13:11:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-sempre-piu-social-ma-il-futuro-e-youtube/ 2019-10-25T15:11:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-la-serata-dei-best-of-2019/ 2020-11-10T08:32:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-sul-q3-la-scure-della-crisi-degli-oppioidi-in-usa/ 2019-10-24T14:11:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-q3-in-chiaroscuro/ 2019-10-24T15:22:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-italia-al-via-campagna-social-awareness-su-hpv/ 2019-10-28T14:18:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-reslizumab-efficace-nellasma-refrattario/ 2019-10-28T15:13:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-la-strada-di-aducanumab-verso-lapprovazione-per-lalzheimer/ 2019-10-28T16:58:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-aumentano-i-guadagni-ma-ordini-piatti/ 2019-10-28T17:29:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-bene-i-farmaci-contro-lhiv-in-calo-yescarta/ 2019-10-28T17:24:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-taltz-e-trulicity-per-le-sfide-del-mercato/ 2019-10-28T16:51:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fresenius-q3-nelle-previsioni/ 2019-10-29T14:54:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-tumore-del-polmone-imfinzi-e-chemio-frenano-progressione-malattia/ 2019-10-29T15:50:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-aumenta-previsioni-per-il-2019-sorpresa-vyndaqel/ 2019-10-29T16:11:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-studio-fase-3-su-un-nuovo-antibiotico-per-le-vie-urinarie/ 2019-10-29T16:50:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-accordo-con-glympse-bio-per-test-non-invasivo-nash/ 2019-10-29T17:23:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-antinfluenzale-universale-un-passo-avanti/ 2019-10-30T09:37:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-aumenta-gli-utili-per-il-2019-con-keytruda-in-ottima-forma/ 2019-10-30T14:45:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assogenerici-sportello-per-le-imprese-sul-nuovo-regolamento-europeo-spc-manufacturing-waiver/ 2019-10-30T17:41:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-nel-q3-tengono-repatha-e-i-biosimilari/ 2019-10-30T15:56:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/piero-angela-excellence-2019-per-la-divulgazione-scientifica/ 2019-10-30T17:21:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-a-cheplapharm-i-diritti-europei-e-russi-di-seroquel/ 2019-10-30T17:32:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-conferma-gli-obiettivi-per-il-2019/ 2019-10-31T14:31:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-alkermes-ok-fda-a-vumerity-nella-sm/ 2019-11-04T10:40:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-alza-ancora-le-previsioni-sugli-utili-annuali/ 2019-10-31T15:08:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-riduce-stime-sulle-perdite-per-lintero-anno/ 2019-10-31T16:32:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gottlieb-i-nuovi-antibiotici-sono-un-buon-investimento/ 2019-10-31T16:31:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-cresce-previsione-vendite-2019/ 2019-11-04T14:15:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-vento-in-poppa-aspettando-allergan/ 2019-11-04T14:45:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-stephen-hahn-e-il-nuovo-capo-dellagenzia-usa/ 2020-11-10T08:54:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/approvazione-condizionata-a-primo-trattamento-per-alzheimer-made-in-china/ 2019-11-04T16:23:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/siemens-healthineers-buone-previsioni-sullonda-lunga-di-un-grande-q3/ 2019-11-04T17:02:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-a-stada-parte-del-portfolio-otc/ 2019-11-05T14:17:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stryker-si-espande-con-lacquisizione-di-wright-medical-group/ 2019-11-05T16:43:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-google-i-dispositivi-indossabili-di-fitbit/ 2019-11-05T14:58:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/karyopharm-q3-trainato-da-xpovio/ 2019-11-05T15:51:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dalluniversita-di-bristol-un-nuovo-naso-elettronico/ 2019-11-05T16:06:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-arriva-in-usa-ziextenzo-biosimilare-di-neulasta/ 2019-11-06T14:22:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-accordo-con-md-anderson-cancer-center-per-lavorare-su-car-nk/ 2019-11-06T14:39:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-lancia-nuovo-fondo-di-investimenti-in-cina/ 2019-11-06T15:01:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-outlook-2019-in-crescita/ 2019-11-06T15:45:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-con-eylea-e-dupixent-q3-alle-stelle/ 2019-11-06T16:45:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/investimenti-e-innovazione-la-ricetta-di-abbvie-italia/ 2019-11-06T18:17:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-efficace-il-vaccino-contro-la-dengue-ma-non-su-tutti-i-tipi-del-virus/ 2019-11-07T13:29:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-distribuira-antitumorali-di-sun-pharma-in-cina/ 2019-11-07T14:06:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-da-oggi-domenico-mantoan-nuovo-presidente-del-cda/ 2019-11-07T14:05:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-nei-laboratori-abbott-diagnostics-scoperto-nuovo-ceppo-dopo-19-anni/ 2019-11-07T14:35:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-accordo-con-samsung-bioepis-per-due-biosimilari-oftalmologici/ 2019-11-07T14:53:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-sma-risdiplam-migliora-funzionalita-motoria/ 2019-11-11T16:26:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-acquista-da-aspen-portfolio-generici-per-il-giappone/ 2019-11-11T14:48:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dupilumab-papi-efficacia-ampiamente-dimostrata/ 2019-11-11T15:01:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-italia-a-milano-il-primo-hackathon-per-le-persone-con-sma/ 2019-11-11T16:42:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/15198/ 2019-11-11T17:08:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-ok-da-aifa-a-rimborsabilita-di-axicabtagene-ciloleucel-terapia-car-t-contro-i-linfomi/ 2019-11-12T17:34:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ok-della-commissione-europea-al-vaccino-contro-ebola/ 2019-11-12T15:21:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-testa-sulluomo-la-tecnologia-brain-shuttle-per-l-alzheimer/ 2019-11-12T15:29:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-accordo-con-ascension-per-cloud-computing-sanitario-in-usa/ 2019-11-12T16:13:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-bene-anifrolumab-nel-les/ 2019-11-12T17:15:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/generici-upjohn-e-mylan-diventeranno-viatris/ 2019-11-13T14:33:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-lancia-let-me-be-clear-per-fare-self-awareness-sulla-psoriasi/ 2019-11-13T18:27:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nektar-bene-combo-bempeg-opdivo-nel-melanoma/ 2019-11-13T15:11:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-il-ceo-miles-white-lascia-a-marzo-2020/ 2020-11-10T08:54:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-bene-cosentyx-nella-spondiloartrite-assiale-non-radiografica/ 2019-11-13T17:55:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-via-la-seconda-edizione-dei-life-science-excellence-awards/ 2020-11-10T08:32:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lancet-keytruda-efficace-nei-tumori-testa-e-collo-metastatici/ 2019-11-14T15:09:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intercept-nuove-evidenze-per-ocaliva-nella-nash/ 2019-11-14T18:03:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apple-lancia-lapp-per-reclutamento-in-studi-clinici/ 2019-11-14T15:57:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-acquista-calporta-per-pipeline-patologie-neurodegenerative/ 2019-11-14T17:02:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-aifa-concede-rimborsabilita-ad-adcetris/ 2019-11-15T14:15:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-brilla-la-stella-mavenclad/ 2019-11-15T14:32:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-scommette-sulla-calvizie/ 2019-11-15T14:54:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cancro-prostata-efficace-la-combo-anti-tgf-beta-yervoy-opdivo/ 2019-11-15T17:44:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ok-a-farmaco-cinese-per-il-linfoma/ 2019-11-15T17:53:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-vaccines-a-rino-rappuoli-il-robert-koch-award/ 2019-11-18T14:20:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-per-ervebo-approvazione-condizionale-ce-e-status-di-prequalificazione-oms/ 2019-11-18T15:07:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-vs-pubmed/ 2019-11-18T17:13:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-celgene-e-fatta-ce-lok-della-federal-trade-commissione/ 2019-11-18T16:29:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-un-nuovo-bioreattore-per-il-vaccino-shingrix/ 2019-11-19T14:01:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-al-via-studio-virtuale-su-invokana/ 2019-11-19T14:13:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-bayer-vericiguat-raggiunge-endopoint-principale-in-studio-insufficienza-cardiaca/ 2019-11-19T15:03:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-con-acoi-corsi-di-perfezionamento-in-chirurgia-bariatrica/ 2019-11-19T15:26:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-aumenta-per-la-seconda-volta-le-stime-per-il-2020/ 2019-11-20T14:38:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/noco-nordisk-dicerna-accordo-per-le-malattie-cardiometaboliche/ 2019-11-20T16:49:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-fda-ad-abrilada-biosimilare-di-humira-abbvie/ 2019-11-20T16:57:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuove-tecnologie-medicali-la-percezione-degli-italiani/ 2019-11-20T16:48:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pasteur-presto-anche-in-italia-vaccino-triaxis-polio/ 2019-11-21T14:38:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nuovi-progetti-per-la-raccolta-dei-dati-real-world/ 2019-11-21T15:24:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alcon-nuova-perdita-trimestrale-dopo-lo-spin-off-da-novartis/ 2019-11-21T15:37:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-i-programmi-del-ceo-jorgensen/ 2020-11-10T08:59:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-italia-federico-chinni-e-il-nuovo-ad/ 2020-11-10T08:54:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ancora-una-conferma-per-tagrisso-dallo-studio-flaura/ 2019-11-22T13:40:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-con-otezla-aumentano-previsioni-2019/ 2019-11-22T13:53:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-allo-studio-tre-possibilita-per-la-bu-consumer-healthcare/ 2019-11-22T16:13:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-acquisisce-the-medicines/ 2019-11-25T14:40:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-ottimi-risultati-per-alunbrig/ 2019-11-25T15:07:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-combo-tecentriq-avastin-funziona-nel-tumore-al-fegato/ 2019-11-25T18:28:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-fda-a-calquence-nella-leucemia-linfatica-cronica/ 2019-11-25T17:12:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-dopo-acquisizione-otezla-aumentano-previsioni-per-il-2019/ 2019-11-26T13:46:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nel-mercato-della-sma-ce-anche-risdiplam/ 2019-11-26T14:50:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-con-inclisiran-riparte-loffensiva-nel-cardiovascolare/ 2019-11-26T16:45:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-tar-respinge-ricorso-contro-delibera-della-toscana/ 2019-11-26T17:48:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-smith-kline-e-fondazione-ricerca-e-salute-insieme-per-la-medicina-digitale/ 2019-11-27T14:39:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/depuy-lancia-nuovo-device-per-fragilita-ossee/ 2019-11-27T17:50:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-xolair-riduce-gravita-ad-nei-bambini/ 2019-11-27T15:27:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/siemens-lancia-nuovo-sistema-per-diagnosi-fibrosi-epatica/ 2019-11-27T15:45:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-geniche-le-big-pharma-investono-nella-produzione-interna/ 2019-11-28T14:54:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immupharma-e-avion-accordo-per-farmaco-contro-il-lupus/ 2019-11-28T15:20:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-torna-a-casa-collaborazioni-con-centri-e-accademie-israeliani/ 2019-11-28T16:58:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/icer-nuovo-criteri-per-la-valutazione-dei-farmaci-contro-lartrite-reumatoide/ 2019-11-28T16:20:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-da-fda-ok-a-revisione-prioritaria-imfinzi-nel-tumore-del-polmone/ 2019-11-29T14:13:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-dal-2020-produzione-europea-di-kymriah-e-zolgensma/ 2019-11-29T14:30:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-per-shingrix-un-sito-di-produzione-dedicato-dal-2024/ 2019-11-29T15:26:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-torna-in-auge-un-candidato-per-la-nash/ 2019-11-29T15:49:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genomics-arriva-primo-test-di-genomica-spaziale/ 2019-12-02T14:31:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/grunenthal-italia-la-comunicazione-a-chiara-lattuada/ 2020-11-10T09:10:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-forti-sconti-dalle-big-pharma-per-accedere-a-rimborsabilita/ 2019-12-02T15:51:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amarin-pfizer-amgen-e-gilead-fra-i-corteggiatori/ 2019-12-02T16:20:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-cede-bu-seprafilm-a-baxter/ 2019-12-03T17:30:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-gruppo-italiano-dedalus-sullit-di-agfa-gevaert/ 2019-12-03T17:29:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lombardia-motore-degli-studi-clinici/ 2019-12-03T15:08:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-shopping-terapie-geniche-acquisita-audentes-therapeutics/ 2019-12-03T15:27:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-chiesi-entro-il-2025-inalatore-spray-per-asma-rispettoso-dellambiente/ 2020-11-10T09:10:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ethicon-lancia-nuovo-sigillante-chirurgico-senza-gas-propellente/ 2019-12-04T14:29:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-celgene-ok-fda-a-combo-tecentriq-abraxane-nel-tumore-al-polmone/ 2019-12-04T15:29:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-nuovi-dati-onco-ematologia-al-congresso-ash/ 2019-12-04T16:00:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-accordo-con-amazon-per-ridisegnare-la-logistica/ 2019-12-05T14:54:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-reblozyl-potenziale-blockbuster-nelle-mds/ 2019-12-05T17:54:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-prostata-una-risposta-da-combo-msd-pfizer-e-astellas/ 2019-12-05T15:03:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-msd-lynparza-sbarca-in-cina/ 2019-12-05T15:34:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-bene-gli-anticorpi-monoclonali-bispecifici-nel-lnh-recidivato-o-refrattario/ 2019-12-09T12:23:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-potenzia-limmunoncologia-acquisita-synthorx/ 2019-12-09T13:30:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/grifols-la-via-dellalbumina-per-la-malattia-di-alzheimer/ 2019-12-09T14:17:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-barra-dritta-sui-generici/ 2019-12-09T14:22:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-un-anno-doro-con-5-potenziali-blockbuster/ 2019-12-09T17:51:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-al-via-il-bvdzero-case-award-per-la-salute-bovina/ 2019-12-09T17:22:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-convegno-sulla-vbhc-a-venezia/ 2019-12-10T11:55:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-dati-sorprendenti-su-yescarta/ 2019-12-10T13:48:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bluebird-bio-da-tre-studi-conferme-di-efficacia-per-lentiglobin/ 2019-12-10T14:22:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-la-rivoluzione-di-dicembre/ 2019-12-11T09:54:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-rafforza-loncologia-con-lacquisizione-di-arqule/ 2019-12-11T14:22:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bluebird-bio-e-bms-risultati-promettenti-per-terapia-sperimentale-mm/ 2019-12-11T15:02:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nash-otto-aziende-da-tenere-sottocchio/ 2019-12-11T18:26:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-inizio-incoraggiante-per-terapia-car-t-nel-mm/ 2019-12-12T13:33:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-taltz-efficace-contro-spondiloartrite/ 2019-12-12T12:31:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-daiichi-sankyo-ottimi-risultati-per-trastuzumab-deruxtecan/ 2019-12-12T17:36:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-le-novita-degli-studi-sul-carcinoma-mammario/ 2019-12-12T15:29:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-partnership-con-unicef-per-sconfiggere-lobesita-infantile/ 2019-12-12T16:15:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-aifa-approva-rimborsabilita-di-pembrolizumab-in-4-neoplasie/ 2019-12-13T14:50:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-da-aifa-rimborsabilita-per-combo-venclyxto-rituximab-nella-llc/ 2019-12-13T15:50:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-e-ufficiale-renato-massimi-direttore-generale-ad-interim/ 2019-12-13T16:47:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sarepta-ok-fda-a-vyondys-53-per-la-dmd/ 2019-12-13T17:01:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-melanoma-efficace-cocktail-a-base-di-tecentriq/ 2019-12-13T17:15:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-presto-dolutegravir-versione-baby-friendly/ 2019-12-17T13:52:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-nuovo-farmaco-per-mm-al-vaglio-della-fda/ 2019-12-17T14:16:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/15464/ 2019-12-17T15:26:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-spark-therapeutics-arriva-il-si-della-ftc/ 2019-12-17T18:41:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-sutimlimab-raggiunge-endpoint-nello-studio-cardinal/ 2019-12-17T17:14:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-profitti-oltre-le-aspettative-per-il-2020/ 2019-12-18T14:40:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-aifa-approva-rimborsabilita-dabrafenib-trametinib-adiuvante-nel-melanoma/ 2019-12-18T15:37:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-italia-ok-da-aifa-a-rimborsabilita-due-nuove-terapie-per-hiv/ 2019-12-18T16:57:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-via-libera-dal-chmp-per-vyndaqel-nellamiloidosi-da-transtiretina-wild-type/ 2019-12-18T17:34:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-entra-nel-regime-di-adempimento-collaborativo-dellagenzia-delle-entrate/ 2019-12-18T17:32:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/molmed-accordo-con-bei-per-linea-di-credito-per-piano-sviluppo/ 2019-12-18T17:34:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biohaven-pharma-efficace-vazegepant-intranasale-nellemicrania/ 2019-12-19T08:36:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/b-braun-medical-jean-claude-dubacher-nuovo-ceo/ 2020-11-10T08:54:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ce-approva-rinvoq-nellartrite-reumatoide/ 2019-12-19T14:21:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-da-fda-accelerated-approval-per-padcev-nel-tumore-della-vescica/ 2019-12-19T14:30:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amylyx-candidato-rallenta-progressione-sla/ 2019-12-19T16:54:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-ai-nel-diabete-con-lacquisizione-di-klue/ 2019-12-20T14:33:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-ce-a-trastuzumab-emtansine-come-terapia-adiuvante-nel-carcinoma-mammario/ 2019-12-20T14:47:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-disco-verde-europeo-per-spravato-nel-trd/ 2019-12-20T15:36:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biofarma-e-nutrilinea-nasce-gruppo-europeo-dei-prodotti-health-care/ 2019-12-20T16:37:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-fda-approva-ervebo-vaccino-contro-ebola/ 2019-12-21T10:48:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eisai-si-da-fda-a-dayvigo-farmaco-per-linsonnia/ 2019-12-23T11:02:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2020-comincia-londa-lunga-delle-terapie-geniche/ 2019-12-23T11:31:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-accordo-con-serapta-per-terapia-genica-contro-dmd/ 2019-12-23T15:17:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-successo-come-cdmo-in-cina/ 2020-01-07T14:30:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-fda-a-lynparza-nel-tumore-del-pancreas-avanzato/ 2020-01-07T14:55:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-acquisisce-xyphos-biosciences/ 2020-01-07T15:16:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-obiettivo-oncogene-kras/ 2020-01-07T15:43:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-cede-lo-stabilimento-di-anagni-a-catalent/ 2020-01-08T11:53:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-merck-kgaa-bene-bavencio-nel-tumore-della-vescica/ 2020-01-08T11:55:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/acquisizioni-e-accordi-2019-anno-record/ 2020-01-08T12:41:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-e-tempo-di-new-science/ 2020-01-08T13:30:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/walgreens-boots-alliance-q1-poco-vigoroso/ 2020-01-08T15:48:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-allergan-nasce-allergan-aesthetics/ 2020-01-09T17:02:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/avexis-novartis-stabilimento-in-colorado-per-aumentare-produzione-zolgensma/ 2020-01-09T10:42:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ok-fda-a-keytruda-nel-tumore-della-vescica/ 2020-01-09T15:00:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-ematologiche-la-parola-al-marketing/ 2020-01-09T15:16:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apellis-competitor-di-alexion-nella-epn/ 2020-01-09T15:45:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-arriva-in-europa-il-neurostimolatore-percept-pc/ 2020-01-10T09:58:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-una-piattaforma-per-i-candidati-nash/ 2020-01-10T12:14:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-chiesi-sponsor-di-parma-capitale-cultura-2020/ 2020-01-10T11:39:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antitumorali-una-speranza-dal-dna-ultra-conservato/ 2020-01-10T14:34:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-obiettivo-2021-per-tre-terapie-candidate/ 2020-01-10T15:23:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-con-demira-diversifica-nella-dermatologia/ 2020-01-13T10:52:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fidia-partnership-commerciale-con-novartis-italia-nelloftalmologia/ 2020-01-13T11:26:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondo-private-equity-su-sorrento-therapeutics/ 2020-01-14T12:43:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-allergan-arriva-lok-della-ce/ 2020-01-13T13:35:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bluebird-bio-lancia-in-germania-la-terapia-genica-per-tdt/ 2020-01-13T17:00:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zentiva-italia-cinzia-falasco-volpin-e-la-nuova-gm/ 2020-01-13T17:40:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/blueprint-fda-approva-ayvakit-per-il-tumore-gist/ 2020-01-14T12:43:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-accordo-ultradecennale-con-illumina/ 2020-01-14T13:08:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-patto-con-il-nhs-per-inclisiran/ 2020-01-14T14:52:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merger-onda-lunga-nel-2020-con-le-biotech/ 2020-01-14T15:29:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-accordo-con-pfizer-per-sindromi-correlate-ad-alzheimer-e-parkinson/ 2020-01-14T16:14:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-nicola-magrini-nuovo-direttore-generale/ 2020-01-15T17:48:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-accordo-con-adaptimmune-per-terapie-cart/ 2020-01-15T16:20:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-come-e-cambiato-il-processo-di-approvazione-dei-farmaci-in-40-anni/ 2020-01-15T14:25:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-dallasia-un-quarto-della-crescita-del-prossimo-decennio/ 2020-01-15T15:50:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-il-prezzo-di-risdiplam-sma-sara-concorrenziale/ 2020-01-15T16:19:45+00:00 monthly 0.2